1631. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Kim M1, Kim TM, Kim KH, Keam B, Lee SH, Kim DW, Lee JS, Jeon YK, Kim CW, Heo DS.
Ann Hematol. 2015 Mar;94(3):437-44. doi: 10.1007/s00277-014-2228-4. Epub 2014 Oct 11.Link
1630. Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer.
Han JJ1, Kim DW2, Koh J3, Keam B1, Kim TM1, Jeon YK3, Lee SH1, Chung DH3, Heo DS1.
Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00270-3. doi: 10.1016/j.cllc.2015.11.006. [Epub ahead of print]Link
1629. The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer.
Lee JK1, Kim DW2, Keam B2, Kim TM2, Lee SH2, Kim YJ3, Heo DS2.
Cancer Res Treat. 2015 Apr;47(2):182-8. doi: 10.4143/crt.2013.227. Epub 2014 Sep 12.Link
1628. Collateral ventilation quantification using xenon-enhanced dynamic dual-energy CT: differences between canine and swine models of bronchial occlusion.
1624. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Moon HH, Kim SH, Ku JL
Oncol Rep. 2016 Jan;35(1):298-306. Epub 2015 Oct 21.Link
1623. High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma.
Hong CR, Kang HJ, Kim MS, Ju HY, Lee JW, Kim H, Kim HS, Park SH, Park KD, Park JD, Shin HY, Ahn HS.
Bone Marrow Transplant. 2015 Oct;50(10):1375-8.Link
1622. Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation.
Kim H, Shin D, Kang HJ, Yu KS, Lee JW, Kim SJ, Kim MS, Song ES, Jang MK, Park JD, Jang IJ, Park KD, Shin HY, Ahn HS.